A carregar...

Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase

Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were included in this prospective study. The incidence of primary end-point (CCS: complete clinical success, defined...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian Heart J
Main Authors: Kiran, G. Ravi, Chandrasekhar, P., Mohammad Ali, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8322749/
https://ncbi.nlm.nih.gov/pubmed/34154758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2021.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!